Mum 'struggles' after losing 11st using Mounjaro jabs
Jade Stalker, 36, weighed 22st 8lbs at her heaviest, after decades of scoffing crisps, Chinese takeaways and piled-high plates of spaghetti Bolognese
A mother has opened up about her body confidence battle, revealing that despite shedding an impressive 11st, she is left feeling unhappy due to "saggy skin". Jade Stalker, 36, from Sauchie, Scotland, once tipped the scales at 22st 8lbs, but the fear of being branded one of the "fat mums" spurred her to slim down dramatically.
Determined not to be judged at the school gates when her daughter began nursery in May 2023, Jade invested £3,500 in gastric sleeve surgery in Turkey, on top of using Mounjaro injections. Now, at a much trimmer 11st 8lbs and with nearly 30 inches gone from her waist, she feels "fantastic".
Despite her weight loss triumph, Jade admitted the physical changes have brought new issues: "The loose skin which makes me depressed and I struggle to look at myself naked sometimes."
She is now crowdfunding, seeking £6,000 for corrective surgery to tackle the unwanted excess skin on her stomach, breasts, and thighs.
Describing the side effects of her dramatic transformation, Jade, a telecommunications engineer, shared: "My skin now is so loose, when I get in the bath, it ripples. I have quite a large overhang on my stomach - and my boobs are saggy, despite my doctors telling me they'd get smaller after losing all the weight."
Despite these challenges, Jade's partner remains supportive, yet Jade confesses: "My partner loves me the way I am - she doesn't care about all that - but I think when you're in a relationship, you do want to look good for your partner."
Jade, who typically dons men's attire and began her journey with a 58in waistline, admits she was never overly concerned about her size. Her daily diet consisted of four ham rolls for breakfast, two packets of crisps as a mid-morning snack, a supermarket meal deal for lunch, and a hearty portion of spaghetti Bolognese with garlic bread for dinner.
However, becoming a mother shifted her perspective. Determined to show her daughter "what a healthy body looks like", she booked flights and a gastric sleeve operation in Turkey for May 2023.
Post-surgery, she found herself unable to finish even three-quarters of a burger, resulting in a weight loss of 5st 8lb within a year.
Despite the significant weight loss, Jade felt the surgery hadn't fully addressed her "head hunger". Consequently, she started a course of Mounjaro, sourced from an online pharmacy, in October 2024.
"The only thing that made me less mentally hungry was Mounjaro," she confessed. "Being on it is like walking through Tesco when you've just had a huge meal."
This led to an additional weight loss of 5st 2lb. Early into her weight loss journey, Jade noticed "saggy skin", initially mistaking it for "fat" that she "still had to lose".
She added: "I'd say my most conscious areas are my stomach, my boobs and my inner thighs - although I'm quite a tomboy so I wear long trousers most of the time.
"I've held off from doing a GoFundMe, but it's getting to the point where it's bothering me so much - even if one or two people could donate, it would be a huge help."
Jade's meals before weight loss
Breakfast: Four ham rolls.
Lunch: A supermarket meal deal, with an extra bag of crisps and a chocolate bar
Dinner: A Chinese takeaway, fish and chips, or a "man-sized" plate of spaghetti Bolognese with garlic bread
Snacks: Nuts, a late-night bag of sweets
Jade's meals after starting Mounjaro
Breakfast: Two slices of toast, with butter
Lunch: Meal deal wrap, with yoghurt and a Ribena Light
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
6 hours ago
- Telegraph
Weight-loss jabs linked to pancreas problems after 10 deaths
Weight-loss jabs have been linked to pancreas problems after 10 patients died. Hundreds of people have reported problems with their pancreas linked to taking weight-loss and diabetes jabs including Mounjaro, Wegovy and Ozempic, prompting health officials to launch a new study into side effects. Ten cases of pancreatitis reported to be linked to GLP-1 medicines (glucagon-like peptide-1 receptor agonists) have been fatal. Since the GLP-1 medicines were licensed, there have been hundreds of cases of acute and chronic pancreatitis, according to data from the medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). These cases are not confirmed as having been caused by the medicines, but the person who reported them suspected they might be. They include 181 reported cases of acute and chronic pancreatitis linked to tirzepatide - the active ingredient for Mounjaro - and five of those people died. Some 116 reported reactions of this kind were linked to liraglutide, one of which was fatal, while there were 113 cases of acute and chronic pancreatitis linked to semaglutide - the active ingredient for Ozempic and Wegovy - where one person died, and 101 reported reactions of this kind were linked to exenatide, from which three people died. Then there were 52 reported reactions linked to dulaglutide and 11 reported reactions linked to lixisenatide, but no fatalities were linked to either drug. Pancreatitis is the inflammation of the pancreas, a gland located behind the stomach that aids in digestion and blood sugar regulation. In severe cases it can lead to organ failure. Nonetheless, the Yellow Card Biobank project, launched by the MHRA and Genomics England, will see researchers examine whether cases of pancreatitis linked to GLP-1 drugs may be influenced by genetic makeup. The MHRA is calling for those who are taking GLP-1 medicine, who have been admitted to hospital due to acute pancreatitis, to submit a report to its Yellow Card scheme. When a Yellow Card report is received, the MHRA will contact patients to ask if they would be willing to take part in the study. Patients will be asked to submit more information and a saliva sample, which will be assessed to explore whether some people are at a higher risk of acute pancreatitis when taking these medicines due to their genes. GLP-1 agonists can lower blood sugar levels in people living with type 2 diabetes and can also be prescribed to support some people with weight loss. Recent estimates suggest that about 1.5 million people in the UK are taking weight-loss jabs. Health officials have suggested they can help turn the tide on obesity, but have stressed they are not a silver bullet and do come with side effects. Most side effects linked to the jabs are gastrointestinal including nausea, constipation and diarrhoea. And the medical regulator recently warned that Mounjaro may make the oral contraceptive pill less effective in some patients. Dr Alison Cave, the MHRA's chief safety officer, said: 'Evidence shows that almost a third of side effects to medicines could be prevented with the introduction of genetic testing, it is predicted that adverse drug reactions could cost the NHS more than £2.2 billion a year in hospital stays alone.' She added: 'Information from the Yellow Card Biobank will help us to better predict those most at risk of adverse reactions - enabling patients across the UK to receive the safest medicine for them, based on their genetic makeup. 'To help us help you, we're asking anyone who has been hospitalised with acute pancreatitis while taking a GLP-1 medicine to report this to us via our Yellow Card scheme. 'Even if you don't meet the criteria for this phase of the Biobank study, information about your reaction to a medication is always extremely valuable in helping to improve patient safety.' Professor Matt Brown, chief scientific officer of Genomics England, said: ' GLP-1 medicines like Ozempic and Wegovy have been making headlines, but like all medicines there can be a risk of serious side effects. 'We believe there is real potential to minimise these with many adverse reactions having a genetic cause. 'This next step in our partnership with the MHRA will generate data and evidence for safer and more effective treatment through more personalised approaches to prescription, supporting a shift towards an increasingly prevention-focused healthcare system.'
Glasgow Times
6 hours ago
- Glasgow Times
Mounjaro could be available on prescription by Glasgow health board
Health board bosses are looking into costings around giving Mounjaro to obese patients whose health they believe could benefit from the slimming jab. The move comes after senior officials at NHS England gave GPs permission to issue the drug to 220,000 severely overweight people with associated health problems over the next three years. In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of over 40 who have at least four other health problems linked to obesity such as type 2 diabetes; high blood pressure; heart disease and obstructive sleep apnoea. Mounjaro, also known as tirzepatide, works by regulating the user's appetite by mimicking a naturally produced hormone called glucagon-like peptide-1 (GLP-1). When we eat, GLP-1 is released and signals sent to the brain to reduce the feeling of hunger. Currently patients in Glasgow can only access the injections through a specialist weight service or at a pharmacy, where the jabs cost around £209 per month. Initially developed for the management of type 2 diabetes, the medication has been licensed in the UK for obesity treatment since November 2024, earning acclaim for its effectiveness in helping with rapid and substantial weight loss. Freedom of Information requests show that 5,866 people are currently being seen by specialist weight loss services in Scotland, but doctors say the number of people who would benefit from a weight loss drug is far higher. After the Scottish Medicines Consortium (SMC) granted approval, there was concern that not all health boards had a weight management service model to support the recommendations - and that the potential level of uptake, along with ongoing supply issues, could pose a challenge for budgets. Any patients being prescribed the drugs on the NHS would need to see a specialist before starting the injections. Professor Naveed Sattar, from Glasgow University, is chair of the UK government's Obesity Mission. He says that when such breakthrough drugs comes along - like statins did 30 years ago - they are expensive at first, but then prices start to fall, making them more widely affordable to health chiefs. Prof Sattar believes the trend would mean medics would then be able to "widen the net" of people who could be prescribed Mounjaro on the NHS. We previously told how Angela Brown reversed her type 2 diabetes and lost five and half stone after turning to the jags, which have also become a favourite of celebrities such as Elon Musk and singer Meghan Trainor. Angela Brown (Image: Colin Mearns) READ NEXT: Cumbernauld woman's surgery goal after Mounjaro weight loss The 52-year-old gran from Cumbernauld tipped the scales at 24 stone and knew she had to quickly shed the pounds to get her health back on track. Angela said: 'I overhauled my diet and lost six stone initially, taking me to 18 stone, but I struggled to shift the rest. I tried everything but nothing seemed to work, then after taking medical advice, I started using Mounjaro and the weight just melted away. It helped my metabolism to kick in and I lost another five and a half stone.' A spokesperson for NHSGGC added: 'We are currently exploring prescribing and monitoring pathways for Mounjaro to patients before inclusion in the GGC formulary.'
Scottish Sun
10 hours ago
- Scottish Sun
I lost 11st thanks to Mounjaro but hate my apron belly & saggy boobs – I need strangers to help me pay for op to fix it
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A MUM who lost 11st with the help of Mounjaro says she "struggles to look at herself naked" after she was left with saggy skin. Jade Stalker, 36, weighed 22st 8lbs at her heaviest, after decades of scoffing crisps, Chinese takeaways and piled-high plates of spaghetti Bolognese. Sign up for Scottish Sun newsletter Sign up 4 Jade Stalker shed an incredible 11st with help from Mounjaro Credit: SWNS 4 But mum Jade has been left with saggy skin that she hates Credit: SWNS 4 She tipped the scales at 22st 8lbs at her heaviest Credit: SWNS 4 Jade has launched an online fundraiser so she can have the excess skin surgically removed Credit: SWNS Just before her daughter, now five, started nursery in May 2023, Jade was concerned she'd be seen as one of the "fat mums" at the school gates - and made a bid to lose 10st. After splashing out £3,500 on flights to Turkey and gastric sleeve surgery, and starting Mounjaro, Jade dropped nearly 30in from her waist and feels "fantastic." But she admits there has been a major drawback when it comes to her weight loss. Now 11st 8lbs, she says she's been left with an "overhang on her stomach" and "saggy" boobs due to excess skin, and added: "The loose skin makes me depressed and I struggle to look at myself naked sometimes." She has launched on online fundraising page to raise £6,000 for surgery to remove excess asking from her stomach, breasts and inner thighs. Jade, a telecommunications engineer from Sauchie, Scotland, said: "My skin now is so loose, when I get in the bath, it ripples. "I have quite a large overhang on my stomach - and my boobs are saggy, despite my doctors telling me they'd get smaller after losing all the weight. "My partner loves me the way I am - she doesn't care about all that - but I think when you're in a relationship, you do want to look good for your partner." Jade, who wears men's clothes and started at a 58in waist, says she's never been bothered about her size. She'd have four ham rolls for breakfast, two bags of crisps as a snack, a Tesco meal deal for lunch and a "man-size" plate of spaghetti Bolognese with garlic bread for dinner. I'm so happy with my Mounjaro body after dropping 4 stone but there's a side effect I hate & trolls say I 'cheated' But becoming a mum changed her view. Wanting to teach her daughter "what a healthy body looks like" she booked flights and a gastric sleeve operation in Turkey, in May 2023. She could barely eat three-quarters of a burger, after the surgery and lost 5st 8lb in a year. But she said the operation hadn't done enough to cure her "head hunger," so began a course of Mounjaro via an online pharmacy in October 2024. "The only thing that made me less mentally hungry was Mounjaro," she said. "Being on it is like walking through Tesco when you've just had a huge meal." Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. About half a million Brits use weight loss drugs - and the number is expected to double in the next year. Mounjaro works by suppressing your appetite, making people feel fuller for longer. The injections are licensed for patients with type 2 diabetes and to assist those who are clinically obese (with a Body Mass Index of 30 or over). One jab is administered each week but the duration is dependent on someone's weight. Jade lost a further 5st 2lb thanks to the jabs. She noticed "saggy skin" early into her weight loss journey but initially thought it was "fat" she "still had to lose". She added: "I'd say my most conscious areas are my stomach, my boobs and my inner thighs - although I'm quite a tomboy so I wear long trousers most of the time. "I've held off from doing a GoFundMe, but it's getting to the point where it's bothering me so much - even if one or two people could donate, it would be a huge help."
